Mpox, formerly known as MonkeyPox, has seen a significant global spread since its outbreak began in May 2022. The virus, caused by an orthopoxvirus, spreads mainly through close contact with an infected person, causing symptoms like a painful rash, enlarged lymph nodes, and fever.
The World Health Organization (WHO) declared the upsurge of mpox in the Democratic Republic of the Congo and its spread to neighboring countries as a public health emergency of international concern on August 14, 2024. The new Clade Ib variant has been causing outbreaks in previously unaffected areas and has spread to countries that had not previously reported mpox.
In the United States, the first case of Clade I mpox was detected in November 2024 following the patient’s travel to an affected area. The global outbreak has affected over 100,000 cases in 122 countries, including 115 countries where mpox was not previously reported. The WHO and other health organizations are working with affected countries to contain these outbreaks and provide necessary resources and guidelines.
Tekedia Mini-MBA edition 16 (Feb 10 – May 3, 2025) opens registrations; register today for early bird discounts.
Tekedia AI in Business Masterclass opens registrations here.
Join Tekedia Capital Syndicate and invest in Africa’s finest startups here.
The new Clade Ib variant of the mpox virus has been detected in four members of a family in the Rheinisch-Bergisch district near Cologne. This includes two school-age children. The initial case was confirmed following a family member’s trip to Africa.
The family is currently under quarantine, and as a precaution, the school attended by the two infected children has been closed, with students switching to remote learning. The health department has identified and informed contact individuals from the school and professional environment about possible symptoms and protective measures.
Curbing the global spread of mpox requires a coordinated and comprehensive approach. Here are some key strategies:
Vaccination: Strategic vaccination efforts focus on individuals at the highest risk, including close contacts of recent cases and healthcare workers. This helps to interrupt transmission chains.
Surveillance and Monitoring: Implementing comprehensive surveillance systems to detect and monitor mpox cases is crucial. This includes tracking the spread of the virus and identifying hotspots for targeted interventions.
Public Awareness and Education: Educating the public about mpox, its symptoms, and preventive measures is essential. This includes promoting hygiene practices, safe handling of animals, and avoiding close contact with infected individuals.
International Collaboration: Coordinated global, regional, and national efforts are necessary to contain mpox outbreaks. This involves sharing information, resources, and best practices among countries and health organizations.
Research and Development: Advancing research on mpox, including the development of diagnostic tests, treatments, and vaccines, is vital. Ensuring equitable access to these medical countermeasures is also important.
Community Engagement: Empowering communities to actively participate in outbreak prevention and control efforts can help reduce the spread of mpox. This includes involving local leaders and organizations in awareness campaigns and response activities
The mpox virus, formerly known as monkeypox, is not very contagious and requires close physical contact for transmission. Symptoms include a skin rash, fever, headaches, and muscle aches. The World Health Organization (WHO) declared a public health emergency of international concern due to the new virus variant and its increasing spread in Africa and part oof Europe especially in cologne Germany.